A comparative study of three concentrations of intravenous nalbuphine combined with hydromorphone for post-cesarean delivery analgesia.
CONCLUSIONS: Hydromorphone 0.05 mg/mL + nalbuphine 0.7 mg/mL for intravenous PCA could effectively improve the incisional pain and uterine cramping pain management and improve comfort in patients after CS.
TRIAL REGISTRATION NUMBER: ChiCTR1800015014, http://www.chictr.org.cn/ Chinese Clinical Trial Registry.
PMID: 32142492 [PubMed - as supplied by publisher]
Source: Chinese Medical Journal - Category: General Medicine Authors: Huang CY, Li SX, Yang MJ, Xu LL, Chen XZ Tags: Chin Med J (Engl) Source Type: research
More News: Breastfed | Cesarean Section | China Health | Clinical Trials | General Medicine | Pain | Pain Management | Parenteral Nutrition | Statistics | Study